The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma

The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma

The clinical benefit of a multidisciplinary clinic practice model has been well described in a variety of medical specialties and cancer types. It proves particularly valuable when an integrated team is needed to optimally manage patients with rare or complex neoplasms. However, the ideal implementa...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology Vol. 5; p. 136
Main Authors: Tyler, Kelly H, Haverkos, Bradley M, Hastings, Justin, Hu, Eileen, Philips, Ramez, Gru, Alejandro A, Welliver, Meng Xu, Mishra, Anjali, Wong, Henry K, Porcu, Pierluigi
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 17-06-2015
Subjects:
Cutaneous
Education
Lymphoma
multimodality
Oncology
multimodality
dermatology
medical education
hematology/oncology
research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The clinical benefit of a multidisciplinary clinic practice model has been well described in a variety of medical specialties and cancer types. It proves particularly valuable when an integrated team is needed to optimally manage patients with rare or complex neoplasms. However, the ideal implementation of an integrated multidisciplinary care program for translational research and education has not been well reported. Herein, we propose how a multimodality cutaneous lymphoma (CL) clinic model can optimally manage CL patients. We offer our perspective on this model as an efficient means for delivering patient care, a continuing education resource for referring physicians, a conduit for translational and clinical research, and an educational tool for medical students, house staff, and fellows.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Juliana Echevarria Lima, Federal University of Rio de Janeiro, Brazil
Specialty section: This article was submitted to Hematology Oncology, a section of the journal Frontiers in Oncology
Reviewed by: Husheng Ding, Mayo Clinic, USA; Alberto Fabbri, Azienda Ospedaliera Universitaria Senese, Italy
Kelly H. Tyler and Bradley M. Haverkos have contributed equally to this work.
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2015.00136